News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

As Big Biotech Talks Cancer Vaccines, Bay Area's Aduro Biotech Nails Mid-Stage Pancreatic Cancer Study



1/15/2014 6:33:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cancer immunotherapy — stimulating the body’s disease-fighting immune system to wrestle cancer — is all the rage among companies and investors at this week’s J.P. Morgan Healthcare Conference.

But a few blocks away, at the American Society of Clinical Oncology’s Gastrointestinal Cancer Symposium at the Moscone Center, tiny Aduro BioTech Inc. is making news Tuesday with results from a mid-stage study in one of the toughest cancers to beat.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES